drugset / Trial / NCT05965570
A Study to Investigate Effect of Clarithromycin, a Strong CYP3A4 Inhibitor, on Brensocatib Pharmacokinetics in Healthy Participants
NaSingle-groupOpen-labelTreatment
Summary
The primary purpose of this study is to determine the effect of clarithromycin on the single-dose pharmacokinetics (PK) of brensocatib in healthy participants.
Timeline
- Start
- 2023-07-28
- Primary completion
- 2023-09-22
- Completion
- 2023-09-22
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Brensocatib | Small molecule | — | Oral |
| Subject | Clarithromycin | Small molecule | — | Oral |
Indications
No indication recorded.